ArticleFrontiers in immunology2025

Povetacicept (ALPN-303; TACI vTD-Fc), an enhanced, potent dual inhibitor of BAFF and APRIL, ameliorates experimental autoimmune myasthenia gravis in C57BL/6N mice.

Elena Rinaldi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.